Avadel Pharmaceuticals (AVDL) Short term Debt (2016 - 2022)
Historic Short term Debt for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to $26.3 million.
- Avadel Pharmaceuticals' Short term Debt changed N/A to $26.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was $26.3 million, marking a year-over-year change of. This contributed to the annual value of $5.6 million for FY2019, which is 4115.9% down from last year.
- Avadel Pharmaceuticals' Short term Debt amounted to $26.3 million in Q3 2022.
- Avadel Pharmaceuticals' 5-year Short term Debt high stood at $26.3 million for Q3 2022, and its period low was $5.6 million during Q4 2019.
- Moreover, its 4-year median value for Short term Debt was $10.2 million (2018), whereas its average is $14.2 million.
- In the last 5 years, Avadel Pharmaceuticals' Short term Debt plummeted by 6536.5% in 2018 and then crashed by 3088.62% in 2019.
- Over the past 4 years, Avadel Pharmaceuticals' Short term Debt (Quarter) stood at $9.4 million in 2018, then plummeted by 41.16% to $5.6 million in 2019, then grew by 5.42% to $5.9 million in 2020, then skyrocketed by 349.17% to $26.3 million in 2022.
- Its last three reported values are $26.3 million in Q3 2022, $26.2 million for Q2 2022, and $26.2 million during Q1 2022.